Secondary, AA, Amyloidosis
作者： Riccardo Papa , Helen J. Lachmann
DOI: 10.1016/J.RDC.2018.06.004
关键词:
摘要: AA amyloidosis, otherwise known as secondary is a complication of chronic inflammation. The amyloid fibrils are derived from the hepatic acute phase reactant, serum A protein. Clinically amyloidosis has predominantly renal presentation with proteinuria and impairment. Untreated disease will progress to end-stage failure. Treatment depends on complete control underlying inflammatory condition, if this can be achieved long-term outcomes favourable. Median survival in patients now exceeds 12 years although failure eventually develops more than 40%.
springer.com
sci-hub.se 参考文章(208)
Noriaki Yorioka, Yoshihiko Taniguchi, Sayuri Okushin, Dai Amimoto, Kazuhiro Kataoka, Takashi Taguchi, Classic polyarteritis nodosa associated with renal amyloidosis. Nephron. ,vol. 82, pp. 93- 94 ,(1999) , 10.1159/000045381
Robert Mahoney, Michael Beardslee, Helen Liapis, Randy G. Cowart, Irmantas Juknevicius, Irfan Agha, Systemic amyloidosis associated with pleomorphic sarcoma of the spleen and remission of nephrotic syndrome after removal of the tumor American Journal of Kidney Diseases. ,vol. 40, pp. 411- 415 ,(2002) , 10.1053/AJKD.2002.34545
E. M. Osman, O. I. Abboud, S. M. Sulaiman, A. R. Musa, O. M. Beleil, A. A. Sharfi, End-stage renal failure in Kartagener's syndrome Nephrology Dialysis Transplantation. ,vol. 6, pp. 747- 747 ,(1991) , 10.1093/NDT/6.10.747
Mingjie Chen, Huibing Zhou, Ni Cheng, Feng Qian, D Ye Richard, None, Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2 Immunobiology. ,vol. 219, pp. 916- 923 ,(2014) , 10.1016/J.IMBIO.2014.08.002
Lee J. Quinton, Matthew T. Blahna, Matthew R. Jones, Eri Allen, Joseph D. Ferrari, Kristie L. Hilliard, Xiaoling Zhang, Vishakha Sabharwal, Hana Algül, Shizuo Akira, Roland M. Schmid, Stephen I. Pelton, Avrum Spira, Joseph P. Mizgerd, Hepatocyte-specific mutation of both NF-κB RelA and STAT3 abrogates the acute phase response in mice. Journal of Clinical Investigation. ,vol. 122, pp. 1758- 1763 ,(2012) , 10.1172/JCI59408
Ruth Gershoni-Baruch, Riva Brik, Nurit Zacks, Maruan Shinawi, Merav Lidar, Avi Livneh, The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis & Rheumatism. ,vol. 48, pp. 1149- 1155 ,(2003) , 10.1002/ART.10944
Kieron S. Leslie, Helen J. Lachmann, Elizabeth Bruning, John A. McGrath, Alison Bybee, J. Ruth Gallimore, Philip F. Roberts, Patricia Woo, Clive E. Grattan, Philip N. Hawkins, Phenotype, Genotype, and Sustained Response to Anakinra in 22 Patients With Autoinflammatory Disease Associated With CIAS-1/NALP3 Mutations Archives of Dermatology. ,vol. 142, pp. 1591- 1597 ,(2006) , 10.1001/ARCHDERM.142.12.1591
Daria Esterházy, Daniel Mucida, Serum Amyloid A proteins take retinol for a ride Trends in Immunology. ,vol. 35, pp. 505- 506 ,(2014) , 10.1016/J.IT.2014.10.001
S. Yamada, Distribution of Serum C-Reactive Protein and Its Association with Atherosclerotic Risk Factors in a Japanese Population : Jichi Medical School Cohort Study American Journal of Epidemiology. ,vol. 153, pp. 1183- 1190 ,(2001) , 10.1093/AJE/153.12.1183
Almudena Escribá, Enrique Morales, Enriqueta Albizúa, Juan Carlos Herrero, Teresa Ortuño, Agustin Carreño, Beatriz Dominguez-Gil, Manuel Praga, Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica. American Journal of Kidney Diseases. ,vol. 35, pp. 137- 140 ,(2000) , 10.1016/S0272-6386(00)70312-X